The expression analysis of the genes belonging to TGFβ1 signaling pathway after treatment with nanocurcumin revealed that this agent can mediate the suppression of telomerase via triggering TGFβ1 pathway, representing the promise of this formulation of curcumin to be used against cancer cells. This evidence concerns the gene TGFB1 and cancer.